HIGHLIGHTS

• PGIMER in Chandigarh is planning to conduct plasma trials to cure Covid-19 patients
• It is collaborating with another Covid-19 centre to launch plama trials
• PGIMER director Jagat Ram said plama therapy as Covid-19 cure holds promise

The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will soon launch trials for Plasma therapy for curing will test it in the COVID-19 patients.

Dr Jagat Ram, Director, PGIMER, told India Today TV on Thursday that the institute will collaborate with another Covid-19 centre to launch the plasma therapy trials soon.

"We have discussed this issue and they are collaborating with some other centre for research and a trial will be done," he said and explained how anti-bodies from a cured patient are drawn and injected to a new patient which can control the virus in the absence of a vaccine.

Ram said that plasma therapy holds promise as it was used during the SARS and MERS epidemic too and the results were favourable.

With regards to the results of hydroxychloroquine use in Covid-19 cases, Ram said currently this drug was being administered to the Covid-19 patients who have mild to moderate symptoms.

The doses are also suggested to the frontline medical health workers including doctors, but only after obtaining their consent.

"Hydroxychloroquine is being administered to the mild to moderate cases of COVID-19 besides the frontline health workers in PGI Chandigarh. This medicine helps decrease the pulmonary spread of pneumonitis. Favourable results have already been found in some COVID-19 cases," the doctor said.

Ram said obtaining consent from the patient is mandatory before putting them on the hydroxychloroquine as it has side effects like cardiac rhythm, muscular, neurological or renal side effects.

"Majority of patients are opting for this medicine as no vaccine is available. We also get consent from our doctors and other staff working in the isolated wards to put them on this medicine," he added.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.pulsus.com/submissions/biomolecules-biochemistry.html) or Author may submit their manuscripts as an e-mail attachment to the Editorial Office at: biomolecules@molecularbiologyjournals.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Mercy| Managing Editor
Journal of Biomolecules and Biochemistry
Whatsapp No:  +1-504-608-2390